Strímvelis (Spanish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Strímvelis" in Spanish language version.

refsWebsite

Global rank Spanish rank

4^th place

4^th place

2^nd place

2^nd place

68^th place

91^st place

99^th place

257^th place

1orchard-tx.com

low place

low place

1fiercebiotech.com

low place

low place

79^th place

179^th place

210^th place

575^th place

1web.archive.org

1^st place

1^st place

low place

low place

49^th place

100^th place

1technologyreview.com

1,943^rd place

2,010^th place

low place

low place

bloomberg.com (Global: 99^th place; Spanish: 257^th place)

Gokhale, Ketaki (1 de abril de 2016). «Glaxo's 'Bubble Boy' Gene Therapy Wins EU Drug Agency Nod». Bloomberg News.
Paton, James (6 de marzo de 2018). «Tiny U.K. Biotech Takes On Glaxo's $730,000 Gene Therapy». Bloomberg.

doi.org (Global: 2^nd place; Spanish: 2^nd place)

dx.doi.org

Candotti F (April 2014). «Gene transfer into hematopoietic stem cells as treatment for primary immunodeficiency diseases». International Journal of Hematology 99 (4): 383-92. PMID 24488786. doi:10.1007/s12185-014-1524-z.
Touzot F, Hacein-Bey-Abina S, Fischer A, Cavazzana M (June 2014). «Gene therapy for inherited immunodeficiency». Expert Opinion on Biological Therapy 14 (6): 789-98. PMID 24823313. doi:10.1517/14712598.2014.895811.
Booth C, Gaspar HB, Thrasher AJ (April 2016). «Treating Immunodeficiency through HSC Gene Therapy». Trends in Molecular Medicine 22 (4): 317-327. PMID 26993219. doi:10.1016/j.molmed.2016.02.002.

europa.eu (Global: 68^th place; Spanish: 91^st place)

ema.europa.eu

«Strimvelis EPAR». European Medicines Agency (EMA). 17 de septiembre de 2018. Consultado el 11 de junio de 2020. Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
«Strimvelis». European Medicines Agency (EMA). Consultado el 13 de abril de 2016.

fiercebiotech.com (Global: low place; Spanish: low place)

Ben Adams for FierceBiotech 4 April 2016 Strimvelis to be the start of a whole new gene therapy platform for GSK and partners

ft.com (Global: 210^th place; Spanish: 575^th place)

Ward, Andrew (1 de abril de 2016). «GSK to allow staggered payments for EMA-approved gene therapy». The Financial Times.

grouph.com (Global: low place; Spanish: low place)

«Does the EU price of Strimvelis create a new 'glass ceiling'? - groupH - Comment =». www.grouph.com. November 2016. Consultado el 26 de febrero de 2017.

gsk.com (Global: low place; Spanish: low place)

«StrimvelisTM receives European marketing authorisation to treat very rare disease, ADA-SCID - GSK». Archivado desde el original el 1 de agosto de 2016. Consultado el 9 de noviembre de 2023.

nih.gov (Global: 4^th place; Spanish: 4^th place)

ncbi.nlm.nih.gov

Candotti F (April 2014). «Gene transfer into hematopoietic stem cells as treatment for primary immunodeficiency diseases». International Journal of Hematology 99 (4): 383-92. PMID 24488786. doi:10.1007/s12185-014-1524-z.
Touzot F, Hacein-Bey-Abina S, Fischer A, Cavazzana M (June 2014). «Gene therapy for inherited immunodeficiency». Expert Opinion on Biological Therapy 14 (6): 789-98. PMID 24823313. doi:10.1517/14712598.2014.895811.
Booth C, Gaspar HB, Thrasher AJ (April 2016). «Treating Immunodeficiency through HSC Gene Therapy». Trends in Molecular Medicine 22 (4): 317-327. PMID 26993219. doi:10.1016/j.molmed.2016.02.002.

orchard-tx.com (Global: low place; Spanish: low place)

«Pipeline». Orchard Therapeutics. 2 de julio de 2021. Consultado el 5 de julio de 2021.

reuters.com (Global: 49^th place; Spanish: 100^th place)

«GSK gives up on rare diseases as gene therapy gets two customers». Reuters. 26 de julio de 2017.

technologyreview.com (Global: 1,943^rd place; Spanish: 2,010^th place)

Regalado, Antonio (6 de mayo de 2016). «Gene Therapy's First Out-and-Out Cure Is Here». MIT Technology Review. Consultado el 12 de mayo de 2016.

web.archive.org (Global: 1^st place; Spanish: 1^st place)

«StrimvelisTM receives European marketing authorisation to treat very rare disease, ADA-SCID - GSK». Archivado desde el original el 1 de agosto de 2016. Consultado el 9 de noviembre de 2023.

wsj.com (Global: 79^th place; Spanish: 179^th place)

Roland, Denise (1 de abril de 2016). «Glaxo's Potential Cure for "Bubble Boy Disease" One Step Closer». The Wall Street Journal.